COST Q1 2026 Earnings EPS Misses Estimates Stock Declines PAPL Q3 2025 Earnings Narrowed Loss Beats Estimates by 51 Edgewise Therapeutics Inc EWTX Q1 2026 Earnings Narrowerthanexpected loss underscores disciplined RD execution Sunrise Realty Trust Inc SUNS Q1 2026 Earnings EPS Surprise of 23 Drives Positive Market Response Silo Pharma Inc SILO Q4 2023 Earnings Widening Losses as PreRevenue Biotech Focuses on Pipeline Progress CMTV Q4 2025 Earnings EPS of 083 Drives Positive Market Reaction CLLS Q1 2026 Earnings NarrowerThanExpected Loss Lifts Shares BEEM Q1 2026 Earnings EPS Misses Estimates as Beam Global Reports WiderThanExpected Loss DLocal Limited Q1 2026 Earnings EPS Misses Estimates Stock Slips PNR Q1 2026 Earnings Solid EPS Surprise Signals Resilient Execution Dermata Therapeutics DRMA Q1 2026 Earnings Narrower Loss Surprises as PreRevenue Biotech Continues Pipeline Progress CVRX Q1 2026 Earnings EPS Beat Driven by Cost Discipline Despite Uncertain Revenue Trajectory